胎心监测仪联合彩色多普勒超声检测胎儿窘迫的临床价值

Clinical Diagnostic Value of Fetal Heart Rate Monitor Combined with Color Doppler Ultrasound in Fetal Distress

目的:探讨并分析胎心监测仪联合彩色多普勒超声对胎儿窘迫的诊断价值。方法:选取2019年10月至2020年5月在三明市第一医院分娩的产妇100例,对其临床资料进行回顾性分析,以新生儿Apgar评分为依据分为两组,即窘迫组(Apgar评分<7分,49例)和健康组(Apgar评分≥7分,51例),两组均实施胎心监测仪联合彩色多普勒超声诊断,观察并记录两组产妇不同时期的脐动脉血流阻力指数(RI)、搏动指数(PI)、收缩期峰值血流速度(S)、舒张末期血流速度(D)、S/D比值等,以及不同产程时的S/D,并进行统计学比较。结果:窘迫组产妇不同孕期RI、PI、S/D均高于健康组,差异具有统计学意义(P<0.05);窘迫组产妇不同产程S/D均高于与健康组,差异具有统计学意义(P<0.05)。结论:临床上对产妇实施胎心监测仪联合彩色多普勒超声诊断,能够通过胎心的监测及对脐动脉血流情况的监测,为诊断人员及时明确胎儿宫内窘迫症状提供准确的指导依据,能够较好地避免不良结局的发生。

Objective To explore and analyze the diagnostic value of fetal heart rate monitor combined with color Doppler ultrasound in fetal distress.Methods 100 parturients who delivered in the First Hospital of Sanming from October 2019 to May 2020 were selected,and their clinical data were analyzed retrospectively,and they were divided into two groups based on the Apgar score of the newborn,namely the distress group(Apgar score<7,49 cases)and healthy group(Apgar score≥7,51 cases),both groups were diagnosed with fetal heart rate monitor combined with color Doppler ultrasound.The umbilical artery blood flow resistance index(RI),pulsatility index(PI),peak systolic blood flow velocity(S),end diastolic blood flow velocity(D),S/D ratio and S/D at different stages of labor were observed and recorded.Results The RI,PI and S/D in the distress group were higher than those in the healthy group at different stages of pregnancy,and the differences were statistically significant(P<0.05).The S/D of different stages of labor in the distress group was significantly higher than that of the healthy group,the difference was statistically significant(P<0.05).Conclusion The clinical application of fetal heart rate monitor combined with color Doppler ultrasound diagnosis for parturients can provide accurate guidance for the diagnosis of fetal distress symptoms in time by monitoring the fetal heart rate and monitoring the blood flow of the umbilical artery,and can better avoid the occurrence of adverse outcomes.